Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Neural Transm Suppl ; (72): 311-5, 2007.
Article in English | MEDLINE | ID: mdl-17982908

ABSTRACT

Methylphenidate (MPH) is a centrally acting (psycho)stimulant which reversibly blocks the dopamine re-uptake transporter. At present MPH is one of the most frequently prescribed drugs for the symptomatic treatment of attention deficit hyperactivity disorder (ADHD). Although MPH has been in use for about 50 years, there is no information available concerning the long-term benefits and risks of medication. Based on experiments in rats it has been suggested that MPH treatment may affect the maturation of central dopaminergic systems and may be a risk factor for the development of Parkinson's disease (PD). The aim of the present case-control study was to gain information about (1) ADHD-like symptoms that may precede PD motor symptoms, and (2) the exposure to psychostimulants in childhood. We used a German short version of the Wender Utah Rating Scale (WURS-k, Retz-Junginger et al., 2002) which is a reliable measure for the retrospective diagnosis of childhood ADHD, and another questionnaire including a rating scale for symptoms of ADHD in childhood (Q-ADHD-Child) according to DSM-IV and ICD-10 criteria. A total of 92 patients with PD and 115 control subjects were enrolled in this study. Ninety-six percentage of PD patients (N = 88) completed the two rating scales. The data of these patients and of 88 randomly selected individuals of the controls were included for analysis. In the WURS-k, the PD group showed higher total scores compared to control subjects. In addition, we found increased scores in PD patients regarding the items attention deficit, hyperactivity and anxious and depressive symptoms, but not regarding impulsivity, oppositional behaviour and deficits in social adaptation. The results of the Q-ADHD-Child also showed increased scores in PD patients regarding attention deficit and hyperactivity. However, one cannot conclude that the PD patients enrolled in this study had suffered from childhood ADHD, since the average total WURS-k score of (14.4) was far below the cut-off score of 30 or higher which is considered to identify childhood ADHD. Finally, we found no evidence that PD patients had been exposed to psychostimulants such as MPH and amphetamine.


Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Central Nervous System Stimulants/adverse effects , Methylphenidate/adverse effects , Parkinson Disease/epidemiology , Adult , Aged , Aged, 80 and over , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/drug therapy , Case-Control Studies , Causality , Central Nervous System Stimulants/therapeutic use , Child , Comorbidity , Female , Humans , Long-Term Care , Male , Methylphenidate/therapeutic use , Middle Aged , Parkinson Disease/diagnosis , Personality Assessment , Retrospective Studies , Risk Factors
2.
Addict Behav ; 26(4): 573-81, 2001.
Article in English | MEDLINE | ID: mdl-11456078

ABSTRACT

To assess relationships between alcohol consumption and two dimensions of drinking restraint (temptation and restriction), American and German college students were given the Khavari Alcohol Test (KAT) and the Temptation and Restraint Inventory (TRI). As hypothesized, drinking temptation was a positive predictor of students' alcohol consumption in both countries, but there was no main effect for drinking restriction. Also as hypothesized, American students who were high on drinking temptation drank greater (not smaller) quantities of alcohol if they were also high on drinking restriction. Conversely, German students who were high on drinking temptation drank more alcohol if they were also low on drinking restriction. The results point to cross-cultural similarities and differences in relationships between drinking temptation and restriction and actual alcohol consumption.


Subject(s)
Alcohol Drinking/psychology , Students/psychology , Adolescent , Adult , Female , Germany , Humans , Male , Surveys and Questionnaires , United States , Universities
3.
J Anxiety Disord ; 14(3): 249-61, 2000.
Article in English | MEDLINE | ID: mdl-10868983

ABSTRACT

The aim of the present study was to investigate whether socially anxious children show deficits in their deliberate facial expression of emotions. To test for potential mother-child transmission effects, the mothers' facial expressions were also assessed. Fifty socially anxious and 25 socially nonanxious children (8-12 years) and their mothers participated in a facial expression posing task. The expressions produced were coded using Ekman and Friesen's (1978) Facial Action Coding System (FACS). In addition, naive raters rated their quality of emotion. FACS analyses indicated that socially anxious children show a reduced general facial activity, have a more restricted facial repertoire and differ qualitatively from controls in their facial expression of emotions. Similarly, the global ratings indicated that the socially anxious children's posed facial expressions are less accurate. For the mothers no differences between groups were found when global ratings were used. However, the FACS data demonstrate that the facial expressions of mothers of socially anxious children are less intense compared to controls. It is possible that the decreased intensity of the mothers' facial expressiveness makes it more difficult for the socially anxious children to learn adequate facial expressions.


Subject(s)
Emotions , Facial Expression , Mothers/psychology , Phobic Disorders/diagnosis , Adult , Child , Discrimination, Psychological , Female , Humans , Male , Mother-Child Relations , Phobic Disorders/epidemiology , Phobic Disorders/psychology , Self Concept , Verbal Behavior , Videotape Recording , Visual Perception
4.
Am J Gastroenterol ; 95(4): 981-94, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10763948

ABSTRACT

OBJECTIVE: Although the standard treatments for the irritable bowel syndrome (IBS) are medical, growing evidence indicates the substantial therapeutic value of psychological therapy. However, it has not been investigated whether the combination of multicomponent behavioral therapy plus medical treatment is more effective than medical treatment alone. The aim of this study was to investigate this question in patients consulting a tertiary gastrointestinal (GI) referral center. METHODS: Twenty-four IBS outpatients were randomly assigned to the combination of standardized multicomponent behavioral therapy plus standard medical treatment (SMBT) or standard medical treatment alone (SMT). SMBT included IBS information and education, progressive muscle relaxation, training in illness-related cognitive coping strategies, problem-solving, and assertiveness training in 10 sessions over 10 wk. SMT included standardized symptom-oriented medical treatment and regular visits to a gastroenterologist every second week. Posttreatment outcome measures consisted of quantification of GI, vegetative, and psychological symptoms by means of daily symptom diaries and the assessment of changes in rectovisceral perception thresholds, as well as of questionnaire measures on psychological distress, overall well-being, illness-related coping abilities, and quality of life. Follow-ups were conducted at 3- and 6-month intervals. RESULTS: Pre- and posttreatment evaluations showed significantly (p < 0.01) greater IBS symptom reduction as measured by daily symptom diaries for the SMBT group than for the SMT group. Rectovisceral perception remained unchanged by either treatment. Overall well-being significantly improved in the SMBT group but remained unchanged in the SMT group. Subjects in the SMBT group, unlike those in the SMT group, felt significantly more in control of their health, and quality of life was significantly improved in the SMBT group but remained unchanged in the SMT group. CONCLUSIONS: The data provide evidence that the combination of medical treatment plus multicomponent behavioral treatment is superior to medical treatment alone in the therapy of IBS.


Subject(s)
Behavior Therapy , Colonic Diseases, Functional/therapy , Adaptation, Psychological , Adult , Colonic Diseases, Functional/psychology , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pain Threshold , Patient Care Team , Quality of Life , Sick Role
SELECTION OF CITATIONS
SEARCH DETAIL
...